Back to All Ideas
Earnings Report·6:49 PM ET · Tuesday, July 28, 2026·4 min read

Core Scientific (CORZ) Q2 2026: Revenue Doubles to $164M on HDC Ramp, AMD Deal Adds 2.5 GW Pipeline

Alpha Stocks Insight Staff

Independent stock news and analysis covering NASDAQ and NYSE markets.

Share

CORZ doubled revenue to $164.2M in Q2 2026 while sealing a 15-year AMD partnership targeting $14B in contracted revenue across 530 MW.

Core Scientific (NASDAQ: CORZ) reported Q2 2026 revenue of $164.2 million, a 108.9% increase from $78.6 million in Q2 2025, as its high-density colocation business scaled rapidly from a standing start. Gross profit expanded to $70.0 million from $5.0 million in the year-ago quarter, reflecting the accelerating contribution of long-term colocation contracts. The company also disclosed a partnership with AMD with potential support for up to 2.5 GW of leasable capacity.

Q2 2026 Results

  • Total revenue: $164.2 million, up 108.9% year-over-year from $78.6 million in Q2 2025
  • Colocation revenue: $136.7 million in Q2 2026, compared with $10.6 million in Q2 2025, reflecting the ramp of high-density colocation services
  • Gross profit: $70.0 million versus $5.0 million in Q2 2025
  • Adjusted EBITDA: $41.1 million, up from $28.5 million in Q2 2025
  • Capital expenditures: $797.5 million, compared with $121.3 million in Q2 2025, a 557.5% year-over-year increase reflecting active data center construction
  • Liquidity: $1.82 billion as of June 30, 2026, versus $754.1 million a year earlier

What Drove the Results

The revenue acceleration was driven by billing megawatts reaching 395 MW in Q2 2026, versus a negligible base in Q2 2025, as Core Scientific converted leased capacity into active, revenue-generating customer deployments. Gross profit of $70.0 million represents a Q2 gross margin of 42.6%, a material improvement from the near-zero margin delivered a year ago when colocation was just beginning to ramp.

The GAAP net loss widened to $1.155 billion from $936.8 million in Q2 2025. The company stated the net loss was primarily driven by non-cash changes in the fair value of warrant liabilities, reflecting appreciation in Core Scientific's stock price during the quarter, rather than operational deterioration. Adjusted EBITDA of $41.1 million, which excludes non-cash items, reflects the underlying operating trajectory more directly.

Capital expenditure of $797.5 million in the quarter, more than six times the $121.3 million deployed in Q2 2025, underscores the scale of infrastructure investment underway. The company reported billing for 437 MW of capacity as of mid-July 2026, representing approximately $635 million in average annualized colocation GAAP revenue.

AMD Partnership and Contracted Revenue Pipeline

Core Scientific announced a partnership with AMD with the potential to support up to 2.5 GW of leasable capacity, anchored by 15-year agreements for approximately 530 MW across five sites and more than $14 billion of potential base contracted revenue. The company's total leased customer power capacity reached approximately 1.1 GW as of the release date, representing more than $24 billion of potential contracted revenue across its customer base. These long-duration agreements provide multi-year revenue visibility tied to physical capacity delivery rather than short-term demand cycles.

Wall Street View

Needham analyst John Todaro reiterated a Buy rating on Core Scientific with a $29 price target following the results. BTIG analyst Gregory Lewis also reiterated a Buy rating, maintaining a $38 price target. Both firms held their existing recommendations without change following the Q2 release.

Investor Takeaway

The Q2 print establishes that Core Scientific's pivot from Bitcoin mining to high-density colocation is producing real revenue at scale, with annualized colocation revenue now running at approximately $635 million based on mid-July billing. The $797.5 million in quarterly capital expenditure, while a significant balance sheet commitment, is largely backstopped by long-term contracted agreements: the AMD deal alone represents more than $14 billion of potential base contracted revenue across 15-year terms, suggesting the capex cycle is demand-driven rather than speculative. Investors watching the path to sustained GAAP profitability should note that warrant liability revaluation, a non-cash item tied to stock price appreciation, is the primary driver of the widening net loss figure.

CORZCore ScientificEarningsData Centers

Found this useful? Share it:

Share

Editorial oversight by Teodora Hristova, Founder & Editor

Related Coverage

Important Legal Disclaimer

This is for informational purposes only and is not financial, investment, or tax advice. Past performance is no guarantee of future results. We are not licensed advisors. For Swiss residents: This does not constitute a public offer under FINSA. For EU residents: Not MiFID II compliant advice. For US residents: Not SEC-registered advice. Always consult a qualified professional. Investing involves risk of loss.

Affiliate disclosure: This site may contain affiliate links to brokerage platforms. If you open an account through one of our links, we may earn a commission at no additional cost to you. Affiliate relationships do not influence our editorial content or stock coverage decisions.

Important Legal Disclaimer: This is for informational purposes only and is not financial, investment, or tax advice. Past performance is no guarantee of future results. We are not licensed advisors. For Swiss residents: This does not constitute a public offer under FINSA. For EU residents: Not MiFID II compliant advice. For US residents: Not SEC-registered advice. Always consult a qualified professional. Investing involves risk of loss.